Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) (ITUB) vs Revvity Inc (RVTY) Price & Performance

Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares)Trade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) vs Revvity Inc — how do they compare? Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) trades at $9.9 (market cap $113.15B), while Revvity Inc trades at $152.05 (market cap $17.14B). The key difference: Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) is far larger — about 6.6× Revvity Inc's market cap, and Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) pays the higher dividend (1.76%). Which is the better fit depends on your goals — on Pluang, investors hold Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) for 0 Days and Revvity Inc for 12 Days on average.

ITUBRVTY
Market Cap
$113.15B$17.14B
Volume
41,687,3202,226,396
Sector
FinancialsHealth
52-Week High
$10.15$157.36
52-Week Low
$6.76$82.26
Typical Hold Time
0 Days12 Days
Enterprise Value
$1.32T$19.46B
Dividend Yield
1.76%0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares)

No Aura AI signal available yet.

Revvity Inc

RVTY trades at $153.60, up 0.2% today and near its 52-week high of $158.28. The stock shows bullish technical momentum with consistent earnings beats in recent quarters. Recent developments include the launch of a new diabetes detection kit in Europe and the acquisition of Human Cell Design to expand metabolic disease research capabilities. Operating cash flow improved to $628 million in 2026 from $583 million in 2025.

RVTY presents growth potential through diagnostic expansion and AI-driven demand, though premium valuation metrics pose near-term risks. The company faces margin pressures in China and competitive challenges. With 52% analyst buy ratings and strong institutional interest, the stock offers upside to the $165 high target but requires monitoring of Q3 earnings due November 3.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ITUB
100% Buy0% Sell
Avg holding period · 0 Days
RVTY

No sentiment data available yet.

Top news

Latest headlines on both assets

About Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares)

Itaú Unibanco is a Brazilian financial services company providing banking, credit, insurance, and investment products. It serves individual, business, and corporate clients.

Read more on ITUB →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →